Literature DB >> 28829989

Suicidal behavior and aggression-related disorders.

Michael S McCloskey1, Brooke A Ammerman2.   

Abstract

Studies of suicidal behavior among those with aggression-related disorders (i.e. intermittent explosive disorder, borderline personality disorder, antisocial personality disorder, and conduct disorder) were examined. The presence of an aggressive disorder generally increased the risk of suicide attempts and mortality, with this effect (when examined) usually existing independent of other psychopathology. However, this may not be the case for antisocial personality disorder. Furthermore, with the exception of intermittent explosive disorder, the extant research suggests severity of aggression was associated with suicide attempt risk in aggression-related disorders. Future research is needed to better understand what mechanisms may influence the suicide-aggression relationship.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28829989     DOI: 10.1016/j.copsyc.2017.08.010

Source DB:  PubMed          Journal:  Curr Opin Psychol        ISSN: 2352-250X


  4 in total

Review 1.  Aggression, Social Stress, and the Immune System in Humans and Animal Models.

Authors:  Aki Takahashi; Meghan E Flanigan; Bruce S McEwen; Scott J Russo
Journal:  Front Behav Neurosci       Date:  2018-03-22       Impact factor: 3.558

2.  Cognitive Conflict in Borderline Personality Disorder: A Study Protocol.

Authors:  Victor Suarez; Guillem Feixas
Journal:  Behav Sci (Basel)       Date:  2020-11-26

Review 3.  Alcohol Use Disorder and Antisocial and Borderline Personality Disorders.

Authors:  Ashley C Helle; Ashley L Watts; Timothy J Trull; Kenneth J Sher
Journal:  Alcohol Res       Date:  2019-12-30

4.  Preliminary validity and reliability evidence of the Brief Antisocial Behavior Scale (B-ABS) in young adults from four countries.

Authors:  Laura Mezquita; Adrian J Bravo; Angelina Pilatti; Generós Ortet; Manuel I Ibáñez
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.